Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Jones

Showing results (501-510 of 654) with videos related to

Pageof 66
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non-Small-Cell Lung Cancer: A Competing Risks AnalysisTakashi Eguchi, Sarina Bains, Ming-Ching Lee, et al.
The Annals of Thoracic Surgery|March 19, 2018
Safety and Feasibility of Lung Resection After Immunotherapy for Metastatic or Unresectable TumorsMatthew J Bott, Jonathan Cools-Lartigue, Kay See Tan, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 30, 2011
Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III studyHiran C Fernando, Rodney J Landreneau, Sumithra J Mandrekar, et al.
Journal of Medicinal Chemistry|August 20, 2011
Virtual screening targeting the urokinase receptor, biochemical and cell-based studies, synthesis, pharmacokinetic characterization, and effect on breast tumor metastasisFang Wang, Jing Li, Anthony L Sinn, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 5, 2011
The impact of adjuvant brachytherapy with sublobar resection on pulmonary function and dyspnea in high-risk patients with operable disease: preliminary results from the American College of Surgeons Oncology Group Z4032 trialHiran C Fernando, Rodney J Landreneau, Sumithra J Mandrekar, et al.
Annals of Surgery|July 14, 2018
More Frequent Surveillance Following Lung Cancer Resection Is Not Associated With Improved Survival: A Nationally Representative Cohort StudyTimothy L McMurry, George J Stukenborg, Larry G Kessler, et al.
Oncotarget|May 7, 2016
Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinomaTakashi Eguchi, Kyuichi Kadota, Jamie Chaft, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 15, 2024
The 2023 American Association for Thoracic Surgery (AATS) Expert Consensus Document: Management of subsolid lung nodulesHaiquan Chen, Anthony W Kim, Michael Hsin, et al.
Anesthesiology|March 9, 2022
Amiodarone with or without N-Acetylcysteine for the Prevention of Atrial Fibrillation after Thoracic Surgery: A Double-blind, Randomized TrialDavid Amar, Hao Zhang, Mina K Chung, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 1, 2024
Late recurrence of completely resected stage I to IIIA lung adenocarcinomaCameron N Fick, Elizabeth G Dunne, Nicolas Toumbacaris, et al.
Pageof 66

Showing results (501-510 of 654) with videos related to

Sort By:
Pageof 66
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non-Small-Cell Lung Cancer: A Competing Risks AnalysisTakashi Eguchi, Sarina Bains, Ming-Ching Lee, et al.
The Annals of Thoracic Surgery|March 19, 2018
Safety and Feasibility of Lung Resection After Immunotherapy for Metastatic or Unresectable TumorsMatthew J Bott, Jonathan Cools-Lartigue, Kay See Tan, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 30, 2011
Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III studyHiran C Fernando, Rodney J Landreneau, Sumithra J Mandrekar, et al.
Journal of Medicinal Chemistry|August 20, 2011
Virtual screening targeting the urokinase receptor, biochemical and cell-based studies, synthesis, pharmacokinetic characterization, and effect on breast tumor metastasisFang Wang, Jing Li, Anthony L Sinn, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 5, 2011
The impact of adjuvant brachytherapy with sublobar resection on pulmonary function and dyspnea in high-risk patients with operable disease: preliminary results from the American College of Surgeons Oncology Group Z4032 trialHiran C Fernando, Rodney J Landreneau, Sumithra J Mandrekar, et al.
Annals of Surgery|July 14, 2018
More Frequent Surveillance Following Lung Cancer Resection Is Not Associated With Improved Survival: A Nationally Representative Cohort StudyTimothy L McMurry, George J Stukenborg, Larry G Kessler, et al.
Oncotarget|May 7, 2016
Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinomaTakashi Eguchi, Kyuichi Kadota, Jamie Chaft, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 15, 2024
The 2023 American Association for Thoracic Surgery (AATS) Expert Consensus Document: Management of subsolid lung nodulesHaiquan Chen, Anthony W Kim, Michael Hsin, et al.
Anesthesiology|March 9, 2022
Amiodarone with or without N-Acetylcysteine for the Prevention of Atrial Fibrillation after Thoracic Surgery: A Double-blind, Randomized TrialDavid Amar, Hao Zhang, Mina K Chung, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 1, 2024
Late recurrence of completely resected stage I to IIIA lung adenocarcinomaCameron N Fick, Elizabeth G Dunne, Nicolas Toumbacaris, et al.
Pageof 66